BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9988118)

  • 1. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?
    Von Lubitz DK
    Eur J Pharmacol; 1999 Jan; 365(1):9-25. PubMed ID: 9988118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?
    von Lubitz DK
    Eur J Pharmacol; 1999 Apr; 371(1):85-102. PubMed ID: 10355598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
    Abbracchio MP; Cattabeni F
    Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A3 receptor stimulation and cerebral ischemia.
    Von Lubitz DK; Lin RC; Popik P; Carter MF; Jacobson KA
    Eur J Pharmacol; 1994 Sep; 263(1-2):59-67. PubMed ID: 7821362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both?
    von Lubitz DK; Ye W; McClellan J; Lin RC
    Ann N Y Acad Sci; 1999; 890():93-106. PubMed ID: 10668416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine receptors in cerebral ischemia.
    Melani A; Pugliese AM; Pedata F
    Int Rev Neurobiol; 2014; 119():309-48. PubMed ID: 25175971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist.
    Von Lubitz DK; Beenhakker M; Lin RC; Carter MF; Paul IA; Bischofberger N; Jacobson KA
    Eur J Pharmacol; 1996 Apr; 302(1-3):43-8. PubMed ID: 8790990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders.
    Bischofberger N; Jacobson KA; von Lubitz DK
    Ann N Y Acad Sci; 1997 Oct; 825():23-9. PubMed ID: 9369972
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists.
    Jacobson KA; Xie R; Young L; Chang L; Liang BT
    J Biol Chem; 2000 Sep; 275(39):30272-9. PubMed ID: 10887176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroprotective mechanisms of adenosine action on CNS neurons].
    Zalewska-Kaszubska J
    Neurol Neurochir Pol; 2002; 36(2):329-36. PubMed ID: 12046508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine as a Key Mediator of Neuronal Survival in Cerebral Ischemic Injury.
    Khan H; Kaur P; Singh TG; Grewal AK; Sood S
    Neurochem Res; 2022 Dec; 47(12):3543-3555. PubMed ID: 36042141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of ischemia-evoked release of excitatory and inhibitory amino acids by adenosine A1 receptor agonist.
    Goda H; Ooboshi H; Nakane H; Ibayashi S; Sadoshima S; Fujishima M
    Eur J Pharmacol; 1998 Sep; 357(2-3):149-55. PubMed ID: 9797030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia.
    Carr CS; Hill RJ; Masamune H; Kennedy SP; Knight DR; Tracey WR; Yellon DM
    Cardiovasc Res; 1997 Oct; 36(1):52-9. PubMed ID: 9415272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right thing at a wrong time? Adenosine A3 receptors and cerebroprotection in stroke.
    Von Lubitz DK; Simpson KL; Lin RC
    Ann N Y Acad Sci; 2001 Jun; 939():85-96. PubMed ID: 11462807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine in the treatment of stroke: yes, maybe, or absolutely not?
    von Lubitz DK
    Expert Opin Investig Drugs; 2001 Apr; 10(4):619-32. PubMed ID: 11281813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist.
    Von Lubitz DK; Lin RC; Bischofberger N; Beenhakker M; Boyd M; Lipartowska R; Jacobson KA
    Eur J Pharmacol; 1999 Mar; 369(3):313-7. PubMed ID: 10225368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine extracellular brain concentrations and role of A2A receptors in ischemia.
    Pedata F; Corsi C; Melani A; Bordoni F; Latini S
    Ann N Y Acad Sci; 2001 Jun; 939():74-84. PubMed ID: 11462806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement.
    Armstrong S; Ganote CE
    Cardiovasc Res; 1994 Jul; 28(7):1049-56. PubMed ID: 7525060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology.
    Shryock JC; Belardinelli L
    Am J Cardiol; 1997 Jun; 79(12A):2-10. PubMed ID: 9223356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.